StepStone Group provides liquidity solution to Gyrus Capital’s LPs in a multi-asset secondary transaction involving dss+ and Essential Pharma
GENEVA, Switzerland, December 12, 2024 – Gyrus Capital, a European investment firm dedicated to transformational investments in the healthcare and sustainability sectors, is pleased to announce the successful closing of a GP-led secondary transaction whereby StepStone Group (Nasdaq: STEP) has provided a liquidity solution to existing investors and strategic capital to support the future growth of two strong performing assets in the healthcare and business services sectors, initially acquired in 2019.
StepStone solely capitalized the transaction on the back of the single-asset continuation vehicle established for Essential Pharma, re-affirming Gyrus Capital’s commitment to support the long-term growth strategy of both dss+ and Essential Pharma.
"We are very proud to have partnered with StepStone in this transaction, having provided an attractive liquidity option to our existing LPs which allowed us to continue the next chapter of growth for both portfolio companies,” said Guy Semmens, Managing Partner at Gyrus Capital. “Working closely with the StepStone team, we were able to engineer a bespoke liquidity solution for our LP base in dss+, while also securing a meaningful investment in the single-asset continuation vehicle established for Essential Pharma.”
About Gyrus Capital
Gyrus Capital is a European investment firm dedicated to transformational investments in the healthcare and sustainability sectors. Based in Geneva, Switzerland, Gyrus invests in businesses that address the structural needs of society and the environment and are positioned for long-term sustainable growth. The firm focuses on complex transactions, particularly corporate carve-outs in the €50 million to €500 million range. A renowned group of experienced partners and industry experts supports Gyrus’s active investment and value-creation approach, working closely with entrepreneurs and managers.
For more information, please visit www.gyruscapital.com
About StepStone Group
StepStone Group Inc. (Nasdaq: STEP) is a global private markets investment firm focused on providing customized investment solutions and advisory and data services to its clients. As of September 30, 2024, StepStone was responsible for approximately $682 billion of total capital, including $176 billion of assets under management. StepStone’s clients include some of the world’s largest public and private defined benefit and defined contribution pension funds, sovereign wealth funds and insurance companies, as well as prominent endowments, foundations, family offices and private wealth clients, which include high-net-worth and mass affluent individuals. StepStone partners with its clients to develop and build private markets portfolios designed to meet their specific objectives across the private equity, infrastructure, private debt and real estate asset classes.
For more information, please visit www.stepstonegroup.com
About dss+
dss+ is a leading provider of specialist operations management consulting services with a purpose of saving lives and creating a sustainable future. dss+ enables companies to build organisational and human capabilities, manage risk, improve operations, achieve sustainability goals and operate more responsibly.
For more information, please visit www.consultdss.com
About Essential Pharma
Essential Pharma operates globally in more than 70 countries, supplying a portfolio of over 300 products across multiple therapeutic areas. Essential Pharma's growth strategy is based on identifying and acquiring mature, at-risk products from larger pharmaceutical groups looking to streamline their product portfolios. It is a trusted partner to multiple pharma companies of all sizes, with a proven history of integrating assets and managing complex technology transfers seamlessly while ensuring continuous and sustainable supply to patients.
For more information, please visit www.essentialpharmagroup.com